Home › Lymphangioleiomyomatosis
Lymphangioleiomyomatosis clinical trials recruiting in the U.S.
6 studies for Lymphangioleiomyomatosis are recruiting participants at sites across the United States.
Cities with the most studies
By state
Recently updated studies
Nebulized or Inhaled Albuterol for Lymphangioleiomyomatosis
RecruitingPhase 1/2
Ages 18 to 100 · Women · Updated Nov 12, 2026 · NCT01799538Study of the Disease Process of Lymphangioleiomyomatosis
RecruitingObservational study
Ages 16 to 100 · All sexes · Updated Nov 5, 2026 · NCT00001465TSC Biosample Repository and Natural History Database
RecruitingObservational study
All ages · All sexes · Updated Jun 24, 2026 · NCT05676099Tuberous Sclerosis Complex and Lymphangioleiomyomatosis Pregnancy Registry (TSC-LAM Registry)
RecruitingObservational study
All ages · Women · Updated Jan 23, 2026 · NCT06160310Evaluating the Long-term Safety and Tolerability of Imatinib in Patients With Lymphangioleiomyomatosis (LAM)
RecruitingPhase 1
Ages 18 to 64 · Women · Updated Jan 21, 2026 · NCT06889168Safety and Durability of Sirolimus for Treatment of LAM
RecruitingObservational study
Ages 18 and older · Women · Updated Dec 24, 2024 · NCT02432560From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.